Prof. Dr. LEVENT ÖNER

Yayın Ağı

Makaleler 58

1. Design, characterization, and in vitro/in vivo evaluation of HER2-targeted immunoliposomes co-functionalized with trastuzumab and iRGD for enhanced delivery of oxaliplatin in gastric cancer therapy

Fidan Y., Aras I. A., SİLİNDİR GÜNAY M., TİMUR S. S., ÖZTÜRK S., ESENDAĞLI G., et al.

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , cilt.113, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

2. İLAÇLARDA SANAL BİYOEŞDEĞERLİK UYGULAMALARI

GÜLSÜN T., DEMİR H., ÖNER L.

Ankara Üniversitesi Eczacılık Fakültesi Dergisi , cilt.48, sa.3, ss.1163-1179, 2024 (Scopus, TRDizin)

3. Development of an RP-HPLC method to evaluate the basic characteristics of talazoparib-loaded PLGA nanoparticles

Topcu B. T., KAPLAN O., Pehlivan S. B., ÇELEBİER M., ÖNER L.

JOURNAL OF CHEMICAL METROLOGY , cilt.18, ss.10-18, 2024 (ESCI, Scopus)

4. Antibody Conjugated Nano-Enabled Drug Delivery Systems Against Brain Tumors

Topçu B. T., Bozdağ Pehlivan S., AKDAĞ ÇAYLI Y., Mut M., ÖNER L.

Journal of Pharmaceutical Sciences , 2024 (SCI-Expanded, Scopus)

5. Current Animal Models Used in Migraine Research Migren Araştırmalarında Kullanılan Güncel Hayvan Modelleri

Kaya M. Z., Bozdağ Pehlivan S., ÖNER L.

Hacettepe University Journal of the Faculty of Pharmacy , cilt.43, sa.4, ss.364-379, 2023 (Scopus)

6. FARMASÖTİK ENDÜSTRİDE FARMA 4.0 YAKLAŞIMI

Bebek G., AKDAG Y., ONER L.

Ankara Üniversitesi Eczacılık Fakültesi Dergisi , cilt.47, sa.3, ss.1058-1070, 2023 (Scopus, TRDizin)

7. Celecoxib Nanoformulations with Enhanced Solubility, Dissolution Rate, and Oral Bioavailability: Experimental Approaches over In Vitro/In Vivo Evaluation

Arslan A., YET B., NEMUTLU E., AKDAĞ ÇAYLI Y., EROĞLU H., ÖNER L.

Pharmaceutics , cilt.15, sa.2, 2023 (SCI-Expanded, Scopus)

8. The development and characterization of electrospun gelatin nanofibers containing indomethacin and curcumin for accelerated wound healing

Gulsun T., Inal M., Akdag Y., İZAT N., ÖNER L., ŞAHİN S.

Journal of Drug Delivery Science and Technology , cilt.67, 2022 (SCI-Expanded, Scopus)

9. Formulation and characterization of mometasone furoate and formoterol fumarate containing dry powder inhaler by spray drying and homogenization methods

AKDAĞ ÇAYLI Y., GÜLSÜN İNAL T., İZAT N., ÖNER L., ŞAHİN S.

JOURNAL OF RESEARCH IN PHARMACY , cilt.26, sa.2, ss.383-396, 2022 (ESCI, TRDizin)

10. Electrospun Nanofibers for Dual and Local Delivery of Neuroprotective Drugs

Haidar M. K., TİMUR S. S., Demirbolat G. M., NEMUTLU E., GÜRSOY R. N., ULUBAYRAM K., et al.

FIBERS AND POLYMERS , cilt.22, sa.2, ss.334-344, 2021 (SCI-Expanded, Scopus)

11. Current status of micro/nanomotors in drug delivery

Tezel G., TİMUR S. S., KURALAY F., GÜRSOY R. N., ULUBAYRAM K., ÖNER L., et al.

JOURNAL OF DRUG TARGETING , cilt.29, sa.1, ss.29-45, 2021 (SCI-Expanded, Scopus)

12. Evaluation of preparation methods for orally disintegrating tablets

AKDAĞ ÇAYLI Y., GÜLSÜN İNAL T., İZAT N., ÇETİN M., ÖNER L., ŞAHİN S.

Medicine Science , cilt.9, sa.1, ss.259-263, 2020 (TRDizin)

13. Development and characterization of metformin hydrochloride- and glyburide-containing orally disintegrating tablets

GÜLSÜN İNAL T., AKDAĞ ÇAYLI Y., İZAT N., ÇETİN M., ÖNER L., ŞAHİN S.

PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY , cilt.25, sa.8, ss.999-1009, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

14. Assessment of Dose Proportionality of Rivaroxaban Nanocrystals

Demir H., GÜLSÜN İNAL T., ÖZKAN M. H., NEMUTLU E., ŞAHİN S., ÖNER L.

AAPS PHARMSCITECH , cilt.21, sa.6, 2020 (SCI-Expanded, Scopus)

15. Characterization and comparison of deferasirox fast disintegrating tablets prepared by direct compression and lyophilization methods

AKDAĞ ÇAYLI Y., GÜLSÜN İNAL T., İZAT N., ÇETİN M., ÖNER L., ŞAHİN S.

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , cilt.57, 2020 (SCI-Expanded, Scopus)

16. Atorvastatin-loaded nanosprayed chitosan nanoparticles for peripheral nerve injury

Haidar M. K., Demirbolat G. M., TİMUR S. S., GÜRSOY R. N., NEMUTLU E., ULUBAYRAM K., et al.

BIOINSPIRED BIOMIMETIC AND NANOBIOMATERIALS , cilt.9, sa.2, ss.74-84, 2020 (SCI-Expanded, Scopus)

17. Comparison of Dissolution Profiles and Apparent Permeabilities of Commercially Available Metformin Hydrochloride Tablets in Turkey

AKDAĞ ÇAYLI Y., GÜLSÜN İNAL T., İZAT N., ÖNER L., ŞAHİN S.

DISSOLUTION TECHNOLOGIES , cilt.27, sa.1, 2020 (SCI-Expanded, Scopus)

18. Neuroprotective Efficiency of Cyclosporine After Traumatic Brain Injury in Rats

Gurcan O., Uckun M. O., Celikmez R. C., Turkoglu O. F., EROĞLU H., Beskonakli E., et al.

TURKISH NEUROSURGERY , cilt.30, sa.4, ss.507-512, 2020 (SCI-Expanded, Scopus, TRDizin)

19. Development and validation of an HPLC method for determination of rofecoxib in bovine serum albumin microspheres

DEMİRTÜRK E., NEMUTLU E., ŞAHİN S., ÖNER L.

TURKISH JOURNAL OF CHEMISTRY , cilt.44, sa.3, ss.647-655, 2020 (SCI-Expanded, Scopus, TRDizin)

20. Preparation and evaluation of phosphate binding capacity of micronized lanthanum carbonate formulation

Pinarbasli O., Şahin S., Eroğlu H., Öner L.

Journal of Drug Delivery Science and Technology , cilt.53, 2019 (SCI-Expanded, Scopus)

21. Cyber-physical-based PAT (CPbPAT) framework for Pharma 4.0

Barenji R. V., Akdag Y., YET B., ÖNER L.

INTERNATIONAL JOURNAL OF PHARMACEUTICS , cilt.567, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

22. Determination of N-acetylcysteine in the presence of ciprofloxacin or levofloxacin in microparticulate dry powder inhalers

Akdag Y., ŞAHİN S., NEMUTLU E., ÖNER L.

TURKISH JOURNAL OF CHEMISTRY , cilt.43, sa.3, ss.846-856, 2019 (SCI-Expanded, Scopus, TRDizin)

23. A snapshot on the current status of Alzheimer’s disease, treatment perspectives, in-Vitro and in-Vivo research studies and future opportunities

Tezel G., TİMUR S. S., Bozkurt İ., Faruk Türkoğlu Ö., EROĞLU İ., NEMUTLU E., et al.

Chemical and Pharmaceutical Bulletin , cilt.67, sa.10, ss.1030-1041, 2019 (SCI-Expanded, Scopus)

24. Effect of particle size and surfactant on the solubility, permeability and dissolution characteristics of deferasirox

Gulsun T., Akdag Y., İZAT N., ÖNER L., ŞAHİN S.

Journal of Research in Pharmacy , cilt.23, sa.5, ss.851-859, 2019 (SSCI, Scopus)

25. Application of an artificial neural network to predict dissolution data and determine the combined effect of pH and surfactant addition on the solubility and dissolution of the weak acid drug etodolac

Demir H., Arica-Yegin B., ÖNER L.

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , cilt.47, ss.215-222, 2018 (SCI-Expanded, Scopus)

26. Development and evaluation of terbutaline sulfate orally disintegrating tablets by direct compression and freeze drying methods

Gulsun T., Cayli Y., İZAT N., ÇETİN M., ÖNER L., ŞAHİN S.

Journal of Drug Delivery Science and Technology , cilt.46, ss.251-258, 2018 (SCI-Expanded, Scopus)

27. Preparation and Characterization of Rivaroxaban Nanocrystals Prepared by Combination of Wet Ball Milling and High Pressure Homogenization Methods

Demir H., GÜLSÜN İNAL T., ŞENER E., ŞAHİN S., ÖNER L.

LATIN AMERICAN JOURNAL OF PHARMACY , cilt.37, sa.12, ss.2482-2490, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

28. Dry Powder Inhalers: Formulations and Aerodynamic Behaviours

AKDAĞ ÇAYLI Y., ŞAHİN S., ÖNER L.

Hacettepe University Journal of the Faculty of Pharmacy , cilt.38, sa.1, ss.39-52, 2018 (Scopus)

29. Dry powders for the inhalation of ciprofloxacin or levofloxacin combined with a mucolytic agent for cystic fibrosis patients.

Akdag C., SAHIN S., BUTTINI F., BALDUCCI A., MONTANARI S., VURAL I., et al.

Drug development and industrial pharmacy , cilt.43, ss.1378-1389, 2017 (SCI-Expanded, Scopus)

30. Development and formulation of floating tablet formulation containing rosiglitazone maleate using Artificial Neural Network

Güler G., EROĞLU H., ÖNER L.

Journal of Drug Delivery Science and Technology , cilt.39, ss.385-397, 2017 (SCI-Expanded, Scopus)

31. Dual release behavior of atorvastatin and alpha-lipoic acid from PLGA microspheres for the combination therapy in peripheral nerve injury

EROĞLU H., Haidar M. K., NEMUTLU E., ÖZTÜRK Ş., BAYRAM C., ULUBAYRAM K., et al.

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , cilt.39, ss.455-466, 2017 (SCI-Expanded, Scopus)

32. Preparation and in vitro/in vivo evaluation of rofecoxib containing bovine serum albumin microspheres

Demirturk E., Gulsun T., Cayli Y., İZAT N., ŞAHİN S., ÖNER L.

Latin American Journal of Pharmacy , cilt.36, sa.6, ss.1096-1104, 2017 (SCI-Expanded, Scopus)

33. Localized delivery of methylprednisolone sodium succinate with polymeric nanoparticles in experimental injured spinal cord model

KARABEY-AKYUREK Y., GURCAY A. G., GURCAN O., TURKOGLU O. F., Yabanoglu-Ciftci S., EROĞLU H., et al.

PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY , cilt.22, sa.8, ss.972-981, 2017 (SCI-Expanded, Scopus)

34. An Improved and Validated HPLC Method for the Determination of Methylprednisolone Sodium Succinate and its Degradation Products in Nanoparticles

KARABEY-AKYUREK Y., NEMUTLU E., BİLENSOY E., ÖNER L.

CURRENT PHARMACEUTICAL ANALYSIS , cilt.13, sa.2, ss.162-168, 2017 (SCI-Expanded, Scopus)

35. Drug Delivery to the Brain: Pharmacokinetic Concepts

ÇOPUR T., ÖNER L.

NANOTECHNOLOGY METHODS FOR NEUROLOGICAL DISEASES AND BRAIN TUMORS: DRUG DELIVERY ACROSS THE BLOOD-BRAIN BARRIER , ss.69-89, 2017 (SCI-Expanded)

36. Beyne İlaç Taşınması ve Dağılımının Farmakokinetiği

ÇOPUR T., PEHLİVAN S., ÖNER L.

Hacettepe Üniversitesi Eczacılık Fakültesi Dergisi , cilt.37, sa.2, ss.81-104, 2017 (Hakemli Dergi) Sürdürülebilir Kalkınma

37. Design and optimization of novel paclitaxel-loaded folate-conjugated amphiphilic cyclodextrin nanoparticles

ERDOĞAR N., ESENDAĞLI G., Nielsen T. T., ŞEN M., ÖNER L., BİLENSOY E.

INTERNATIONAL JOURNAL OF PHARMACEUTICS , cilt.509, ss.375-390, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

38. Systematic development of pH-independent controlled release tablets of carvedilol using central composite design and artificial neural networks

Aktas E., EROĞLU H., Kockan U., ÖNER L.

Drug Development and Industrial Pharmacy , cilt.39, sa.8, ss.1207-1216, 2013 (SCI-Expanded, Scopus)

39. Preparation and characterization of nimesulide containing nanocrystal formulations

Gulsun T., Budak C., VURAL İ., ŞAHİN S., ÖNER L.

PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY , cilt.18, sa.3, ss.653-659, 2013 (SCI-Expanded, Scopus)

40. Preparation and in vitro/in vivo evaluation of microparticle formulations containing meloxicam

EROĞLU H., Burul-Bozkurt N., Uma S., ÖNER L.

AAPS PharmSciTech , cilt.13, sa.1, ss.46-52, 2012 (SCI-Expanded, Scopus)

41. Design and Characterization of Nanocrystal Formulations Containing Ezetimibe

Gulsun T., GÜRSOY R. N., ÖNER L.

CHEMICAL & PHARMACEUTICAL BULLETIN , cilt.59, sa.1, ss.41-45, 2011 (SCI-Expanded, Scopus)

42. Local administration of chitosan microspheres after traumatic brain injury in rats: a new challenge for cyclosporine - a delivery

TURKOGLU O. F., EROĞLU H., GURCAN O., BODUR E., SARGON M. F., ÖNER L., et al.

BRITISH JOURNAL OF NEUROSURGERY , cilt.24, sa.5, ss.578-583, 2010 (SCI-Expanded, Scopus)

43. A Quadruped Study on Chitosan Microspheres Containing Atorvastatin Calcium: Preparation, Characterization, Quantification and in-Vivo Application

EROĞLU H., NEMUTLU E., TURKOGLU O. F., NACAR O., BODUR E., SARGON M. F., et al.

CHEMICAL & PHARMACEUTICAL BULLETIN , cilt.58, sa.9, ss.1161-1167, 2010 (SCI-Expanded, Scopus)

44. EVALUATION OF SOLUBILITY CLASS OF WEAK ACIDIC DRUG: ETODOLAC

Demir H., Yegin B., ÖNER L.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.38, sa.1, ss.80-82, 2009 (SCI-Expanded)

45. FORMULATION OF CHITOSAN COATED SODIUM ALGINATE MICROCAPSULES CONTAINING MELOXICAM

EROĞLU H., ÖNER L.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.38, sa.1, ss.93-95, 2009 (SCI-Expanded)

46. Nanocrystal Technology for Oral Delivery of Poorly Water-Soluble Drugs

GÜLSÜN İNAL T., GÜRSOY R. N., ÖNER L.

FABAD Journal of Pharmaceutical Sciences , cilt.34, sa.1, ss.55-65, 2009 (Scopus)

47. Validation of the analytical method for in-vivo determination of meloxicam and bioequivalence study from meloxicam containing microparticle formulations in rabbits In-vivo Meloksikam Miktar Tayininin Validasyonu ve Tavşanlarda Meloksikam içeren Mikropartiküller ile Biyoeşdeǧerlik Çalişması

EROĞLU H., Burul-Bozkurt N., Uma S., ÖNER L.

Hacettepe University Journal of the Faculty of Pharmacy , cilt.29, sa.2, ss.115-130, 2009 (Scopus)

48. Determination of valdecoxib from pharmaceutical formulations and in-vitro comparison of dissolution profiles

EROĞLU H., ÖNER L.

Hacettepe University Journal of the Faculty of Pharmacy , cilt.28, sa.1, ss.31-48, 2008 (Scopus)

49. Chitosan in steroid delivery: Formulation of microspheres by factorial design and evaluation of in-vitro release parameters

EROĞLU H., Alpar R., ÖNER L.

Fabad Journal of Pharmaceutical Sciences , cilt.33, sa.3, ss.145-152, 2008 (Scopus)

50. A comparative study of treatment for brain edema: Magnesium sulphate versus dexamethasone sodium phosphate

TURKOGLU O. F., EROĞLU H., OKUTAN O., TUN M. K., BODUR E., SARGON M. F., et al.

JOURNAL OF CLINICAL NEUROSCIENCE , cilt.15, sa.1, ss.60-65, 2008 (SCI-Expanded, Scopus)

51. Chitosan formulations for steroid delivery: Effect of formulation variables on in vitro characteristics

EROĞLU H., Sargon M. F., ÖNER L.

Drug Development and Industrial Pharmacy , cilt.33, sa.3, ss.265-271, 2007 (SCI-Expanded, Scopus)

52. Efficiency of chitosan film formulation following experimental brain edema

EROĞLU H., Türkoǧlu Ö. F., Okutan Ö., Gürcan O., BODUR E., Sargon M. F., et al.

Fabad Journal of Pharmaceutical Sciences , cilt.31, sa.1, ss.15-21, 2006 (Scopus)

53. The efficiency of dexamethasone sodium phosphate-encapsulated chitosan microspheres after cold injury

Turkoglu O. F., EROĞLU H., Okutan O., Burul E., Sargon M. F., Özer N., et al.

Surgical Neurology , cilt.64, 2005 (SCI-Expanded, Scopus)

54. Effect of glutamine supplementation on diarrhea, interleukin-8 and secretory immunoglobulin a in children with acute diarrhea

YALCIN S. S., YURDAKOK K., TEZCAN T., Oner L.

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION , cilt.38, sa.5, ss.494-501, 2004 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

55. The effect of recombinant human erythropoietin on serum selenium levels in hemodialysis patients

CELIKER A., GIRAY B., BASAY T., Oner L.

JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY , cilt.15, sa.4, ss.215-220, 2001 (SCI-Expanded, Scopus)

56. In vitro/in vivo characterization of bovine serum albumin microspheres containing dexamethasone sodium phosphate

EROGLU H., KAS H., Oner L., TURKOGLU O., AKALAN N., SARGON M. F., et al.

STP PHARMA SCIENCES , cilt.10, sa.4, ss.303-308, 2000 (SCI-Expanded, Scopus)

57. Development and validation of a capillary electrophoretic method for the determination of degradation product in naphazoline HCl bulk drug substance

Yesilada A., TOZKOPARAN B., GOKHAN N., ONER L., ERTAN M.

JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES , cilt.21, sa.17, ss.2575-2588, 1998 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

58. Cyclophosphamide loaded albumin microspheres. IV. Application of factorial design

VURAL İ., Kas H., ÖNER L., Hincal A.

S.T.P. Pharma Sciences , cilt.1, sa.5, ss.318-320, 1991 (SCI-Expanded, Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 62

1. Dry Powder Inhaler Formulations Containing Gefitinib Nanoparticles

Geyik Z. M., Nacak B., Bilal M. N., Gülsün İnal T., Şahin S., Öner L., et al.

9th BBBB International Conference on Pharmaceutical Sciences 2022, Ljubljana, Slovenya, 15 - 17 Eylül 2022, ss.178-179, (Özet Bildiri)

2. Effects of modifications in methyl cellulose nanoparticle production methods on particle size distribution

Taş B., Akdağ Çaylı Y., Pehlivan S., Aytekin E., Çopur T., Sağlam O., et al.

20th International Pharmaceutical Technology Symposium - IPTS 2022, 21 - 23 Şubat 2022, ss.1-2, (Tam Metin Bildiri)

3. Gefitinib-human serum albumin nanoparticles production by nanoparticle-albumin bound (NAB™) technology

Geyik Z. M., Nacak B., Bilal M. N., Gülsün İnal T., Şahin S., Öner L., et al.

20th International Pharmaceutical Technology Symposium - IPTS 2022, 21 - 23 Şubat 2022, ss.1-2, (Tam Metin Bildiri)

4. Effects of Production Method Variations on Particle Size Distribution of Ethyl Cellulose Nanoparticles

Taş B., Akdağ Çaylı Y., Aytekin E., Pehlivan S., Öner L.

13th International Symposium on Pharmaceutical Sciences (ISOPS), 22 - 25 Haziran 2021, ss.1-2, (Tam Metin Bildiri)

5. Application of Central Composite Design in the optimization of blank poly(lactic-coglycolic acid) nanoparticles

ÇOPUR T., PEHLİVAN S., YET B., ÖNER L.

8th BBBB International Conference on Pharmaceutical Sciences, 14 - 16 Ekim 2019, (Tam Metin Bildiri)

6. Optimization of blank poly(lactic-coglycolic acid) nanoparticle formulations using Artificial Neural Networks

ÇOPUR T., PEHLİVAN S., YET B., ÖNER L.

8th BBBB International Conference on Pharmaceutical Sciences, 14 - 16 Ekim 2019, (Tam Metin Bildiri)

7. Validation of HPLC method for the determination of Carbenoxolone disodium

ÇOPUR T., KURT N., PEHLİVAN S., ÖNER L.

8th BBBB International Conference on Pharmaceutical Sciences, 14 - 16 Ekim 2019, (Tam Metin Bildiri)

8. Effects of Preparation Methods on Orally Disintegrating Tablets

AKDAĞ ÇAYLI Y., GÜLSÜN İNAL T., İZAT N., ÇETİN M., ÖNER L., ŞAHİN S.

International Multidisciplinary Symposium on Drug Research Development (DRD 2019), 1 - 03 Temmuz 2019, (Tam Metin Bildiri)

9. Effects of Preparatıon Methods On Orally Disıntegrating Tablets

AKDAĞ ÇAYLI Y., GÜLSÜN İNAL T., İZAT N., ÇETİN M., ÖNER L., ŞAHİN S.

International Multidisciplinary Symposium on Drug Research and Development (DRD 2019, Malatya, Türkiye, 1 - 03 Temmuz 2019, (Tam Metin Bildiri)

10. Ağız yolu ile uygulanan etkin maddelerin çözünürlük ve permeabilite özelliklerini arttırmak amacıyla formülasyon geliştirme sürecinde kullanılan yöntemler

AKDAĞ ÇAYLI Y., GÜLSÜN İNAL T., İZAT N., ŞAHİN S., ÖNER L.

2. Ulusal Marmara Eczacılık Kongresi (UMEK-2), Türkiye, 14 - 16 Kasım 2018, (Özet Bildiri)

11. OPTIMIZATION OF NANOSYSTEMS CONTAINING ALBUMIN LINKED PACLITAXEL

AKDAĞ ÇAYLI Y., MURAT Z., EROĞLU H., ÖNER L.

19th International Pharmaceutical Technology Symposium, 17 - 19 Eylül 2018, (Tam Metin Bildiri)

12. Development of Novel Polymeric Nanofibrous Composite Containing Nanoparticles For Dual And Localized Neuroprotective Drug Delivery

HAİDAR M. K., DOĞAN S. S., GÜRSOY R. N., NEMUTLU E., DEMİRBOLAT G. M., ULUBAYRAM K., et al.

19th International Pharmaceutical Technology Symposium-IPTS 2018, 17 - 19 Eylül 2018, (Tam Metin Bildiri)

13. Application of A Novel Polymeric Electrospun Nanocomposite Incorporating Neuroprotective Drugs In Rat Sciatic Nerve Injury Model

HAİDAR M. K., Timur S. S., GÜRSOY R. N., NEMUTLU E., DEMİRBOLAT G. M., TÜRKOĞLU Ö. F., et al.

19th International Pharmaceutical Technology Symposium, 17 - 19 Eylül 2018, (Tam Metin Bildiri)

14. Development ofbiodegredable nanoparticles for the brain delivery of Ketorolac Tromethamine

KURT N., ÇOPUR T., PEHLİVAN S., ÖNER L.

19th InternationalPharmaceutical Technology Symposium, 17 - 19 Eylül 2018, (Tam Metin Bildiri)

15. In Vitro Cytotoxicity Study of Chitosan Nanoparticles Containing Atorvastatin Calcium For Treatment Of Peripheral Nerve Injury

HAİDAR M. K., DOĞAN S. S., GÜRSOY R. N., NEMUTLU E., DEMİRBOLAT G. M., ULUBAYRAM K., et al.

19th International Pharmaceutical Technology Symposium-IPTS 2018, 17 - 19 Eylül 2018, (Tam Metin Bildiri)

16. Effect of various formulation parameters on the characteristics of blank PLGA nanoparticles

ÇOPUR T., PEHLİVAN S., ÖNER L.

12th International Symposium on Pharmaceutical Sciences (ISOPS), 26 - 29 Haziran 2018, (Özet Bildiri)

17. Investigation of deferasirox permeability from lyophilized orally disintegrating tablet

GÜLSÜN İNAL T., İZAT N., AKDAĞ ÇAYLI Y., ÖNER L., ŞAHİN S.

2017 AAPS Annual Meeting and Exposition, 12 - 15 Kasım 2017, (Özet Bildiri)

18. Investigation of terbutaline sulfate permeability from orally disintegrating tablets

İZAT N., AKDAĞ ÇAYLI Y., GÜLSÜN İNAL T., ÖNER L., ŞAHİN S.

2017 AAPS Annual Meeting and Exposition, 12 - 15 Kasım 2017, (Özet Bildiri)

19. Development and Characterization of Indomethacin and Curcumin Containing Nanofibers

İNAL M., GÜLSÜN İNAL T., İZAT N., AKDAĞ ÇAYLI Y., ÖNER L., ŞAHİN S.

GPSS 2017, 11 - 13 Ekim 2017, (Özet Bildiri)

20. Drug delivery for neuroprotection: Opportunuties and challenges

EROĞLU H., TÜRKOĞLU Ö. F., SARGON M. F., HAİDAR M. K., DEMİRBOLAT G. M., ÖZTÜRK Ş., et al.

3rd International Multidisciplinary Symposium on Drug Research and Development, 5 - 07 Ekim 2017, (Özet Bildiri)

21. Development and Evaluation of Lyophilized Orally Disintegrating Tablets Containing Metformin Hydrochloride and Glyburide

AKDAĞ ÇAYLI Y., GÜLSÜN İNAL T., İZAT N., ÇETİN M., ÖNER L., ŞAHİN S.

77th FIP World Congress of Pharmacy and Pharmaceutical Sciences 2017, 10 - 14 Eylül 2017, (Özet Bildiri)

22. Drug delivery applications for neuroprotection: Nanoparticles, nanofibers, microparticles

EROĞLU H., TÜRKOĞLU Ö. F., SARGON M. F., HAİDAR M. K., DEMİRBOLAT G. M., ÖZTÜRK Ş., et al.

3rd International Congress of the Greek Local Chapter of the Controlled Release Society, 19 - 20 Haziran 2017, (Özet Bildiri)

23. Formulation of atorvastatin calcium loaded chitosan nanoparticles by nano-spray drying method for sustained drug delivery

HAİDAR M. K., DEMİRBOLAT G. M., NEMUTLU E., ULUBAYRAM K., ÖNER L., EROĞLU H.

3rd International Congress of the Greek Local Chapter of the Controlled Release Society, 19 - 20 Haziran 2017, (Özet Bildiri)

24. Antibiyotik İçeren Kuru Toz İnhaler Formülasyonları

AKDAĞ ÇAYLI Y., ŞAHİN S., ÖNER L.

1. Anadolu Üniversitesi Eczacılık Fakültesi Sempozyumu (ANES), Türkiye, 1 - 02 Haziran 2017, (Özet Bildiri)

25. Novel Folate-Conjugated Amphiphilic Cyclodextrin Nanoparticles For Paclitaxel Delivery in Recurrent Metastatic Breast Cancer

ERDOĞAR N., ESENDAĞLI G., NIELSEN T. T., ESENDAĞLI YILMAZ G., SARGON M. F., ÖNER L., et al.

Innovation in Medicine Summit-3, 11 - 13 Mayıs 2017, (Özet Bildiri) Sürdürülebilir Kalkınma